L-carnitine supplementation in patients with cystic acne on isotretinoin therapy

Journal of the European Academy of Dermatology and Venereology

Volumn 13, Issue 3, 1999, Pages 205-209

  Georgala, Sophia ^a   Schulpis, Kleopatra H ^b   Georgala, Catherina ^a   Michas, Timos ^a  

^a A Syngros Hospital   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Cystic acue; Isotretinoin; L carnitine

Indexed keywords

CARNITINE; ISOTRETINOIN; LIPID; LIVER ENZYME; PLACEBO;

ACNE CYSTICA; ADULT; ARTICLE; CARNITINE DEFICIENCY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ASSAY; FEMALE; HUMAN; HYPOTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MUSCLE RIGIDITY; MUSCLE WEAKNESS; MYALGIA; PRIORITY JOURNAL;

ACNE VULGARIS; ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; CARNITINE; CASE-CONTROL STUDIES; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOTRETINOIN; KERATOLYTIC AGENTS; LIVER; MALE; MUSCLE WEAKNESS; MUSCULAR DISEASES; PAIN; PLACEBOS; TRIGLYCERIDES;

EID: 0032693854     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(99)00105-1     Document Type: Article

References (19)

1. Walter I. Carnitine. Arch Dis child 1996;14:475-478.
2. Bieber LL. Carnitine. Ann Rev Biochem 1988;57:261-283.
3. Rebuche CI. Carnitine function and requirements during the life cycle. FASEB I 1992;6:3379-3386.
4. Thurston I, Stautiart R. Amelioration of adverse effects of valproic acid on ketogenesis and liver coenzyme A metabolism by co-treatment with pantothenate and carnitine in the developing mice. Possible clinical significance. Pediatr Res 1992;31:419-423.
5. Opala G, Winter S, Vance C. The effect of Valproic acid on plasma carnitine levels. Am I Dis Child 1991;145:999-1001.
6. Melegh B, Kerner. I., Ascadia, G. L-carnitine replacement therapy on chronic Valproic treatment. Neuropediatr 1990;21:40-43.
7. Mills C, Marks R. Adverse reactions to oral retinoids. Drug Safety 1993;9:280-290.
8. Katz RA, Mergensen H, Nigra T. Elevation of serum triglyceride levels from oral Isotretinoin. Arch Dermatol 1980;116:1369-1372.
9. McGarry ID, Foster DW. An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. J Lipid Res 1976;17:277-281.
10. Georgala S, Schulpis K, Potouridou I. Effects of Isotretinoin therapy on lipoprotein (a) serum levels. Int J Dermatol 1997;36:863-864.
11. Marsen IR. Lipid metabolism and retinoid therapy. Pharm Ther 1989;40:55-65.
12. Fagher B, Cederblad G, Eriksson M. L-carnitine and haemodyalisis double blind study on muscle function and metabolism. Scand I Clin Lab Invest 1985;45:169-178.
13. Rogerson ME, Rylane PB, Wilson R. Carnitine and weakness in heamodialysis patients. Nephron Dial Transplant 1989;4:366-371.
14. Melegh B, Pap M, Morava E. Carnitine dependent changes of metabolic fuel consumption during long term treatment with Valproic. J Pediatr 1994:25:317-321.
15. Stantley CA, Delleu S, Coates PM. Chronic cardiomyopathy and weakness in children with a defect in carnitine uptake. Pediatr Res 1996;120:76-80.
16. Erikson BO, Gustafsen B, Nordin I. Transport of carnitine into cells in hereditary carnitinedeficiency. J Inher Metab Dis 1989;12:108-111.
17. Mantel H, Africk D, Blutter M. The importance of recognising secondary carnitine deficiency in organic acidaenias J Inher Metab Dis 1988;11:397-402.
18. Chanda S, Mehendale H. Role of nutritional fatty acid and L-carnitine in the final outcome of thioacetamide hepatotoxicity. FASEB I 1994;8:1061-1068.
19. Schulpis KH, Nounopoylos C, Tsagarakis S. Serum carnitine levels in phenylketonouric children under dietary control. Acta Pediatrica 1990;79:930-934.